Request Trial
river-rainforest-brazil
31 July 2013AmericasGabriel Di Blasi

Current barriers to biotech in Brazil

The Brazilian government intends to improve regulation for patents, especially in the biotechnology sector. Last March, the Brazilian Minister of Development, Industry and Foreign Trade announced measures to improve the Brazilian regulations related to patents, especially in the field of biotechnology, mainly with regard to changing the rules of IP law and permits for research in biotech.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Merchant & Gould hires 13 attorneys to open new Boston office
6 January 2026   The new recruits from a boutique Boston firm enables Merchant to expand and strengthen its tech and life sciences offering in the innovation hub.
Americas
PTAB year in review: A shifting landscape and outlook for 2026
2 January 2026   With the unprecedented changes at the PTAB in 2025, what could the year ahead hold for the agency? Lawyers from Sterne Kessler explore.
Americas
5 ways the USPTO director is changing US innovation
24 December 2025   John Squires has rewired the country’s patents system since becoming USPTO director—but which changes are most impactful? Sarah Speight explores.


Editor's picks

Who are the world’s best in-house counsel? Final call for the leading corporate IP professionals
Europe
Who are the world’s best in-house counsel? Final call for the leading corporate IP professionals
8 January 2026

Editor's picks

Europe
Who are the world’s best in-house counsel? Final call for the leading corporate IP professionals
8 January 2026
Europe
Abbott appeals ‘baffling’ decision in glucose monitoring device feud
16 December 2025
Americas
Teva scrubs 200-plus Orange Book patents after FTC turns the screw
11 December 2025
Americas
US govt backs Hikma over ‘skinny label’ rules
9 December 2025
Big Pharma
The clinical trial dilemma: Navigating European practice
27 November 2025
Europe
Biotech cleared to make biosimilar of $6bn treatment after landmark ruling
25 November 2025

More features

Who are the world’s best in-house counsel? Final call for the leading corporate IP professionals
Merchant & Gould hires 13 attorneys to open new Boston office
Key EU and UK regulatory changes to watch for in 2026
PTAB year in review: A shifting landscape and outlook for 2026
From Edwards to Insulet: Three key medical device cases of 2025
5 ways the USPTO director is changing US innovation
Mirum targets generics in quartet of suits over liver treatment
WATCH: Enabling success — overcoming §112 in the new era of life sciences patents